ISRCTN42536405已完成未知
Cabergoline and OHSS - a randomized controlled study
Samir Abbas Center (Saudi Arabia)0 个研究点目标入组 200 人开始时间: 2011年7月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. 200 infertile couples undergoing ICSI and at risk of developing OHSS have been included between January 2007 and July 2009
- •2. The risk to develop OHSS has been defined as follows:
- •2.1. Dopamine E2 level on day of hCG > 3500 pg/ml
- •2.2. With = 20 follicles > 12 mm
排除标准
- •Patients with dopamine E2 =5000 pg/ml
研究者
相似试验
已完成
3 期
A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLSRestless Legs SyndromeNCT00627003Pfizer43
已完成
不适用
Cabergoline and Coasting to Prevent OHSSOHSSNCT01984320Cairo University300
已完成
3 期
Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS BiomarkersOvarian Hyperstimulation SyndromeNCT01535859KK Women's and Children's Hospital46
已完成
3 期
Comparing the effects of cabergoline and hydroxychloroquine to prevent ovarian hyperstimulation syndromePolycystic ovary syndrome.Polycystic ovarian syndromeE28.2IRCT20240305061171N1Tehran University of Medical Sciences40
已完成
不适用
Assigning the effect of administration of cabergoline on uterine perfusion in women with polycystic ovary syndromeIRCT201009154755N1Kurdistan University of Medical Sciences40